Editorial: Mass spectrometry-based proteogenomics - advances in mutant proteomics and clinical oncology

Front Oncol. 2024 Mar 21:14:1383838. doi: 10.3389/fonc.2024.1383838. eCollection 2024.

Authors

Akos Végvári¹, Toshihide Nishimura²

Affiliations

¹ Department of Medical Biochemistry and Biophysics, Karolinska Institutet (KI), Stockholm, Sweden.
² Department Chest Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

No abstract available

Keywords: biomarker; clinical oncology; mass spectrometry-based proteogenomics; mutant proteomics; treatment-strategy development.

Publication types

Editorial